DK352578A - Fremgangsmaade til fremstilling af et farmaceutisk praeparat - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat

Info

Publication number
DK352578A
DK352578A DK352578A DK352578A DK352578A DK 352578 A DK352578 A DK 352578A DK 352578 A DK352578 A DK 352578A DK 352578 A DK352578 A DK 352578A DK 352578 A DK352578 A DK 352578A
Authority
DK
Denmark
Prior art keywords
preparation
procedure
pharmaceutical
pharmaceutical preparation
Prior art date
Application number
DK352578A
Other languages
English (en)
Other versions
DK153443B (da
DK153443C (da
Inventor
Y Yamamura
I Azuma
O Aoki
Original Assignee
Y Yamamura
I Azuma
O Aoki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Y Yamamura, I Azuma, O Aoki filed Critical Y Yamamura
Publication of DK352578A publication Critical patent/DK352578A/da
Publication of DK153443B publication Critical patent/DK153443B/da
Application granted granted Critical
Publication of DK153443C publication Critical patent/DK153443C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK352578A 1977-08-09 1978-08-09 Fremgangsmaade til fremstilling af fast farmaceutisk praeparat indeholdende cellevaegsskelet fra nocardia rubra DK153443C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9587177 1977-08-09
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (3)

Publication Number Publication Date
DK352578A true DK352578A (da) 1979-02-10
DK153443B DK153443B (da) 1988-07-18
DK153443C DK153443C (da) 1988-12-05

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
DK352578A DK153443C (da) 1977-08-09 1978-08-09 Fremgangsmaade til fremstilling af fast farmaceutisk praeparat indeholdende cellevaegsskelet fra nocardia rubra

Country Status (15)

Country Link
US (1) US4543253A (da)
JP (1) JPS5428813A (da)
AU (1) AU526788B2 (da)
BE (1) BE869610A (da)
CA (1) CA1118348A (da)
CH (1) CH643459A5 (da)
DE (1) DE2834893A1 (da)
DK (1) DK153443C (da)
FI (1) FI65370C (da)
FR (1) FR2399844A1 (da)
GB (1) GB2002229B (da)
HU (1) HU179726B (da)
IT (1) IT1098381B (da)
NL (1) NL7808337A (da)
SE (1) SE447629B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
CA2337445A1 (en) * 1998-07-16 2000-01-27 Sumitomo Pharmaceuticals Co., Ltd. Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (da) * 1974-04-25 1978-07-21 Anvar
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens

Also Published As

Publication number Publication date
FI65370B (fi) 1984-01-31
IT7826609A0 (it) 1978-08-08
FI65370C (fi) 1984-05-10
CH643459A5 (de) 1984-06-15
BE869610A (fr) 1979-02-08
GB2002229B (en) 1982-05-26
DK153443B (da) 1988-07-18
CA1118348A (en) 1982-02-16
SE7808414L (sv) 1979-02-10
IT1098381B (it) 1985-09-07
DE2834893C2 (da) 1987-08-27
DK153443C (da) 1988-12-05
JPS5428813A (en) 1979-03-03
SE447629B (sv) 1986-12-01
FI782442A7 (fi) 1979-02-10
HU179726B (en) 1982-11-29
AU526788B2 (en) 1983-02-03
GB2002229A (en) 1979-02-21
DE2834893A1 (de) 1979-02-22
NL7808337A (nl) 1979-02-13
AU3879178A (en) 1980-02-14
US4543253A (en) 1985-09-24
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (da) 1982-08-20
JPS631291B2 (da) 1988-01-12

Similar Documents

Publication Publication Date Title
DK151931C (da) Fremgangsmaade til fremstilling af et farmacentisk praeparat i enhedsdosisform
DK153773C (da) Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK160739C (da) Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK247078A (da) Fremgangsmaade til fremstilling af et krystallinsk natrium-silicoaluminat
DK569678A (da) Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider
DK484677A (da) Fremgangsmaade til fremstilling af furokumariner
DK527078A (da) Fremgangsmaade til fremstilling af et polysaccharid
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK466878A (da) Fremgangsmaade til fremstilling af 0-methallyloxyphenol
DK523277A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK351578A (da) Fremgangsmaade til fremstilling af en kornformet oxymethylenpolymer
DK330178A (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK436978A (da) Fremgangsmaade til fremstilling af sarcosinoxidase
DK5778A (da) Femgangsmaade til fremstilling af 4-diphenylmethylen-1-hydroxybenzyl-piperidiner
DK577078A (da) Fremgangsmaade til fremstilling af trans-4a-aryloctahydro-1h-2-pyridiner
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK568278A (da) Fremgangsmaade til fremstilling af et pharmaceutisk praeparat
DK383978A (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner
DK339777A (da) Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner

Legal Events

Date Code Title Description
PBP Patent lapsed